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Investigations in the field of small bowel transplan-
tation have been carried out since 1959 in various 
experimental settings using animal transplantation 
models, and these have provided comparatively 
good knowledge of the rejection reaction. Still, the 
relevance ofthe graft-versus-host reaction (GVHR) 
in small bowel transplantation has thus far re-
mained doubtful. From a theoretic point of view, 
G VHR might play an important role in small bowel 
transplantation, because the small bowel graft con-
tains a considerable number of immunocompetent 
cells in both the Peyer's patches and the mesenteric 
lymph nodes. These cells can be stimulated by host 
antigens and can attack the recipient immunologi-
cally [1]. 
The early results of experimental small bowel 
transplantation and the case reports of disastrous 
human small bowel grafting gave no clear evidence 
ofGVHR [2]. Several investigators observed signs of 
G VHR after canine small bowel transplantation 
(3-5], whereas no GVHR could be demonstrated 
after small bowel transplantation in the pig model 
[6,7], and even recent reports give only an indistinct 
description of GVHR in small bowel transplanta-
tion [8]. 
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The reason for this indistinct description of 
G VHR-related phenomena lies in the undefined im-
munogenetic situation in allogeneic canine or pig 
transplantation. In these models, simultaneously 
occuring host-versus-graft reaction and GVHR in-
terfere with each other; therefore, GVHR cannot 
express itself clearly. The first attempts to charac-
terize GVHR insmall bowel transplantation more 
exactly were made by Monchik and Russell [ 9] using 
parenteral strain donors and F 1 hybrid recipients 
from inbred rat strains, which thus made a unidirec-
tional GVHR possible. These investigators were 
able to show distinct signs of GVHR which resem-
bled those first described by Sirnonsen [ 1 0]. 
Since the first description of G VHR, its elucida-
tion and prevention seems to be among the indis-
pensible prerequisites for clinicalsmall bowel trans-
plantation. As a continuation of the aforementioned 
experiments, we carried out an investigation to de-
scribe GVHR and its underlying mechanisms in 
small bowel transplantation and tried to find meth-
ods of circumventing it. 
Material and Methods 
A semiallogeneic donor recipient combination was es-
tablished by using Brown Norway (RTl n) donor rats and 
Brown Norway- Lewis (RT11) F1 hybrid recipients. 
The operative procedure, which has been described in 
detail elsewhere [11], consists of accessory heterotopic 
transplantation of donor small bowel (Figure 1). The por-
tal vein and the superior mesenteric artery ofthe graft are 
anastomosed to the recipient's inferior vena cava and 
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TABLE II Survlval Ratea 
Group Treatment n % 
1 No treatment 0/26 0 
2 Cyclosporlne 20/28 71 
3 Donor irradiatlon 20126 77 
4 Removal of mesenteric 23/26 89 
lymph nodes 
abdominalaorta, respectively. The oral end of the graft is 
closed and the distal end is anastomosed to the recipient's 
terminal ileum. 
Four experimental groups were formed (Groups 1, 2, 3, 
and 4) (Table 1). The 26 animals in Group 1 received no 
further treatment. The 28 animals in Group 2 received 15 
mg of cyclosporine perkilogram body weight orally for 14 
days, beginning with the firstpostoperative day. The 26 
donors of Group 3 received irradiation consisting of 950 
rads. The grafts were removed within 15 hours after irra-
diation. InGroup 4 (26 animals), the mesenteric lymph 
nodes of the graft were removed microsurgically. This 
technique has been described elsewhere (ll]. 
The cytotoxic antihost activity ofT lymphocytes from 
different lymphatic compartments of the graft (namely, 
the mesenteric lymph nodes and Peyer's patches) and the 
recipient smalJ bowel (namely, the mesenteric lymph 
nodes, Peyer's patches, peripheral cervicallymph nodes, 
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Flgure 2. Group 1rst st sutD~My14 dBys posloperatlvely. Arrows 
to thelett lndlcste the reclplent'• smsll bowe/; s"ow to the rlgiJI 
lndlcat•• lhe gratt. 
and spieen) and in the recipient's blood was measured by 
a microcytotoxicity assay [12] using Lewis rat fibroblasts 
as target cells for determining GVHR activity. Specific 
Iysis, which was determined by subtracting the cytotoxici-
ty of syngeneically transplanted control animals from the 
cytotoxicity of semiallogeneic Groups 1 through 4, was 
expressed by the integral (cm2) of a curve that resulted 
from the cytotoxicity values of different dilutions of T-
cell suspensions. It is quoted as the mean ± standard 
error. The microcytotoxicity assay was performed at 14 
days (Group 1), 20 to 30days, and 82 to 120 days (Groups 
2, 3 and 4) after transplantation. The statistical evalua-
tion was carried out by means of the Wilcoxon-Mann-
Whitney rank-sum test. Histologie examination of all the 
aforementioned tissues was performed with Specialatten-
tiontoT -dependent areas of the lymph nodes and spieen. 
Results 
All animals in Group 1 died within 22 days after 
transplantation (Table II). Beginning with the 10th 
postoperative day, the animals lost weight, had di-
anhea, and developed severe exfoliative dermatitis. 
As these symptoms became aggravated, the animals 
died. Autopsy revealed a characteristic pattern 
(Figure 2) with the graft intact. The mesenteric 
lymph nodes, however, were greatly enlarged (Fig-
ure 3). The recipient small bowel was thin walled 
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Flgure 3. Group 1 rat. SIHnlallogeMic small bOwel graft { arrow) 
14 . days aller Iransplantat/on wlth enlarged mesenlerlc lymph 
nodes. 
and blown up with gas. Both the spieen (spieen 
index: 5.4 ± 3.3) and the peripherallymph nodes 
were enlarged. Histologie examination of the graft 
(Figure 4) showed anormal bowel wall. The para-
cortical area of the mesenteric lymph nodes of the 
graft showed evidence of maximum immunologic 
stimulation in the form of proliferation of immun-
oblasts and macrophages (Figure 5). These signs 
reached their maximum expression at day 14 after 
transplantation and did not disappear until the 
death of the recipient. The small bowel of the recipi-
Flgure 5. Group 1 rat. Paracorllcal area 
of meNnterlc lymph n«Jes of the grafl 
wlth pro/lferat/on ol lmmunob/Ms (I) 
and macrophages ( Af) 14 days 
postoperatlvely. ( Glemsa staln; 
magnlflcatlon X 400.) 
Volume 151, March 11186 
Graft-Versus-Host Reactlon 
Figura 4. A Hmlallogenelc grafl lrom a Group 1 rat 14 days 
postoperatlvely. All comparlments ot lhe bowel wa/1 appsar 
normal. ( G#emsa slaln; magnlflcatlon X 160.) 
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ent showed signs of severe erosive enteritis with 
infiltration of the Iamina propria by numerous im-
munoblasts and activated lymphatic cells that 
caused erosion of mucosal epithelium. Similar to the 
T -dependent areas of the graft's mesenteric lymph 
nodes, the paracorticai areas of the peripheral 
lymph nodes and the periarteriolar sheaths of the 
recipient's spieen also showed strong immunologic 
stimulation in the form of proliferation of the im-
munocompetent cells (Figure 6). 
The antihost T-cell cytotoxicity values in the mi-
crocytotoxicity assay (Figure 7, Table III) showed 
high GVHR activity in alllymphatic compartments 
except the Peyer's patches of the graft and the re-
cipient. Extremely high graft versus host activity 
could be shown in the recipient's blood. 
Twenty of 28 animals in Group 2 (71 percent) 
survived until150 days after transplantation (Table 
II). Clinical signs of runting disease appeared only 
in two animals. Autopsy showed that the graft and 
the recipient small bowel were normal both macro-
scopically and histologically. No enlargement ofthe 
mesenteric lymph nodes of the graft could be shown. 
Histologie evaluation of the paracortical area of 
these lymph nodes revealed no immunologic stimu-
lation either 20 or 110 days after transplantation. 
The peripherallymph nodes of the recipient were 
not enlarged nor could a proliferation of immuno-
logic stimulation in the periarteriolar sheath be 
shown. The recipient's spieen showed no immuno-
logic stimulation in the periarteriolar sheath (Fig-
ure 8). 
Antihost T-cell activity in Group 2 (Figure 7, 
Table 111) bad decreased to zero in the mesenteric 
lymph nodes of the graft 20 and 110 days after the 
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Flgure 6. Sp/Hn ot reclplent ln Group 1 
14 days postoperallvely wlth 
prollleratlon of lmmunocompetent ~~,. 
ln lhe perlarterlolar aheat,.,._ (GI.""" 
.,aln; magnfflcatlon X 400.) 
Operation. Graft versus host activity in the spieen 
had disminished significantly (p <0.01) compared 
with Group 1 20 days postoperatively and reached 
zero 100 days after transplantation. The antihost 
activity found in the host Peyer's patches was not 
significantly düferent from that in Group 1 either 
20 or 110 days postoperatively. No blood reactivity 
could be found. After irradiation of the donor ani-
mals (Group 3), 20 of 26 (77 percent) survived in 
good health until 120 days after transplantation. 
Twenty-three of 26 recipients (89 percent) of grafts 
with the mesenteric lymph nodes removed (Group 
4) survived until120 days after transplantation (Ta-
ble 11). Autopsy findings and histologic features of 
these two groups were similar. 
The grafts and the small bowels of the recipients 
were normal, as was the histologic picture of the 
small bowel grafts. The mesenteric lymph nodes of 
the grafts in Group 3 showed no evidence of immu-
nologic stimulation. The spieen and cervicallymph 
nodes of Group 3 and 4 animals revealed a normal 
histologic picture both 30 and 120 days postopera-
tively. 
In Group 3, antihost cytotoxicity had decreased 
to zero (Table 111, Figure 9) in the graft compart-
ments, although on the 30th postoperative day, dis-
tinct T -cell reactivity could be found in the Peyer's 
patches and the spleens of the recipients. This was 
not significantly different from that of Group 1. 
Blood reactivity was zero on the 30th and 120th 
days. The same holds true for the reactivity in all 
other compartments. In Group 4, reactivity (Table 
111, Figura 9) bad decreased to zero in a1l graft and 
donor compartments except the spieen during both 
periods oftime. The spieen reactivity was, however, 
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Flgure 7. Anl/host T-ce/1 cytotoxlclty values of the 
mlcrocytotoxlclfy auy ln Gtou". 1 and 2. 71N mean ± .,andard 
error ot tiHI mean .,. lndlcaled. B = blood; ltiLN = "....",.,.lc 
lymph ~ ltiLNGR = meHntfJrlc lymph nodn ot fllalt; PLN • 
p•lpherallymph node~ PP= Peyer's patchft; PPGR = Pey«'s 
patches of graft; S = sp/Hn. 
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significantly reduced (p <0.002 at 29 days and p 
<0.05 at 82 days) compared with Group 1. 
Comments 
After small bowel transplantation in all animals 
that had received a semiallogeneic small bowel graft 
without any treatmelit, a characteristic clinical pic-
ture developed that was identical to the runting 
syndrome that occurs in the course of GVHR, as 
described for the first time by Sirnonsen [ 1 0] after 
injection of immunocompetent cells. In the semial-
logeneic donor-recipient combination chosen in our 
experimental model for immunogenetic reasons, an 
immunologic attack by donor cells against host anti-
gens can develop without interference frotn HVGR. 
This experimental setting was chosen for the flrst 
time by Monchik and Russell [ 9] in their pioneering 
experiments on small bowel transplantation in the 
rat. The semiallogeneic small bowel transplantation 
in this experimental design revealed a clear-cut 
morphologic and functional pattem of GVHR. A-
side from the skin, the small bowel of the recipient is 
a main target of antihost reactions [ 13]. The damage 
done to these epithelial organs by immunocompe-
tent cells of the donor seems to be the main reason 
for the death of the recipients. 
Lymphatic tissues of the grafts and recipients 
also show a very strong histologic alteration in the 
course of G VHR, thus demonstrating that lymphat-
ic tissue is another main target of graft-versus-host 
reactions [ 1]. 
Immunologie stimulation of donor cells in the 
TABLE 111 Antiholt T-C.II Cytotoxlclty Yaluea of Mlcrocytotoxlclty A~~ay• 
No. Postop 
Group Tested Oay B st Pl.N MLN PP MLNGR PPGR 
14 d 11 14 ± 2.4 49.7 ± 12 32 ± 6.8 9.1 ± 3.5 11.5 ± 4.6 0 11.5 ± 5.9 0 
postop 
2 
20.9d 10 20 ± 7.2 0 9 ±3.9 7.8 ± 0.9 0 11.5 ± 17.2 0 0 
postop 
110.2 d 6 110.2 ± 18.7 0 0 0 0 16.5 ± 18.5 14.7 ± 8.1 0 
postop 
3 
30.1 d 7 30.1 ± 0.9 0 27.8 ± 9 0 0 18 ± 5.5 0 0 
postop 
120.6 d 10 120.6 ± 34.4 0 0 0 0 0 0 0 
postop 
4 
28.7d 7 28.7 ± 2.2 0 5 ± 1.2 0 0 0 0 
postop 
82.2d 9 82.2 ± 31.1 0 16 ± 7.5 0 4± 3.5 0 0 
postop 
• Statlstical values are the mean ± the Standard error of the mean. 
t p <O.O 1 for the antlhost T -cell cytotoxlclty value ln Group 2 20.9 days postoperatlvely versus that ln Group 1: p <0.002 for Group 4 28.7 
days postoperatlvely veraus that ln Group 1; and p <0.05 for Group 4 82.2 days postoperatlvely versus that ln Group 1. 
B = blood; MLN = mesenterlc lymph nodes; MLNGR = mesenterlc lymph nodes of graft; PLN = perlpheral lymph nodes; PP = Peyer' s 
patches; PPGR = Peyer's patches of graft; S = spleen. 
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Flgure 8. Normal appearance of the perlarter/olar sheath of the 
reclplllnt's BpiHn ln Group 2 14 days po61operatlvely. ( GlemBB 
Blaln; magnNicatlon X 400.) 
macroscopically enlarged mesenteric lymph nodes 
ofthe graft, which can be seen histologically, repre-
sents the induction of GVHR in a donor compart-
ment, whereas histologic alterations in the recipi-
ent's lymphatic tissues represent the continuing 
proliferation of donor cella in the recipient. 
Functional data from the microcytotoxicity assay 
representing the effective activities of GVHR are in 
complete accordance with these morphologic find-
ings, since strong histologic stimulation corre-
sponds directly to distinct values of antihost cyto-
toxicity. The most outstanding feature of flour-
ishing GVHR (Group 1) is the high rate of antihost 
cytotoxic activity in the blood of small bowel recipi-
ents. 
For the expression of strong GVHR which Ieads to 
the death of the recipients (Group 1), a distinct 
antihost reactivity that is not locked into the lym-
phatic compartments and also appears at a high 
Ievel within the blood seems to be characteristic. 
The decrease in this blood reactivity in the experi-
mental groups after donor and recipient treatment 
(Groups 2, 3, and 4) acconipanied by the marked 
increase in the survival rates (Table li) is the most 
remarkable result of these experiments. This find-
ing underlines the significance af the antihost reac-
tivity found in the recipient's blood for the effects of 
GVHR. 
In the cyclosporine-treated Group 2, in addition 
to the decrease in this blaod antihast activity, the 
antihast activity in the lymphatic compartments 
was found tobe eliminated (Table 111, Figure 7). 
The spieen reactivity 20 days after transplantation 
was significantly different from that in Group 1 {p 
<0.01). Peripherallymph node reactivity at 20 days 
postoperatively did not differ from the values in 
Group 1. The reactivity of the recipients' Peyer's 
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Flgure 9. Antlhost T-ce/1 cytotoxlclty values of the 
mlcrocytotoxlcHy assay ln Groups 3 and 4 • .,.". nHian ± Blandard 
error of the mean are lndlcated. 
was higher than in Peyer's patches of Group 1 ani-
mals. One hundred ten days after transplantation, 
antihost reactivity in all campartments except the 
recipient's Peyer's patches disappeared, despite the 
fact that administration of cyclosporine ceased after 
14 days. 
The morphologic pattern in the T -dependent 
areas of the mesenteric lymph nodes of the graft 
represents the immunologic stimulation of the im-
munocompetent cells of the graft against donor 
antigen and the pattern in the T -dependent areas of 
the spieen of the recipient, their continuing prolifer-
ation within the recipient. Since these findings are 
absent after administratian of cyclosporine, it can 
be concluded that cyclosporine is capable af sup-
pressing the induction of antihost-directed immu-
nologic stimulation of G VHR after small bowel 
transplantation. Not only the inductive phase of 
GVHR is influenced by cyclosporine, but also the 
antihost effector activities ofT lymphocytes in the 
peripheral blood and the lymphatic compartments 
of the graft and recipient, thus causing avoidance of 
GVHR and survival of the recipients. This is shown 
by analysis of the functional parameters in the mi-
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crocytotoxicity assay. Cyclosporine can thus sup-
press both the inductive phase of the antihast im-
mune response (sensitization), as far as can be 
concluded from the histologic data, and the effector 
phase ofGVHR, as is revealed by functional investi-
gations. The decisive prerequisite for this graft-
versus-host suppressing effect is the administration 
of cyclosporine immediately after small bowel 
transplantation during the sensitization period of 
GVHR. Once the development of GVHR has been 
hampered, cyclosporine can be discontinued. 
The reason why an unaltered high antihast reac-
tivity remains in the Peyer's patches is unclear. 
Since cyclosporine alters the lymphocyte migration 
patterns in cardiac allograft models [ 14], the in-
crease in antihast activity in Peyer's patches in 
small bowel transplantation might be caused by 
alteration of lymphocyte migration behavior in cy-
closporine-treated animals. 
Sublethai irradiation of the donors also has a 
GVHR-suppressing effect. Animals survive and 
show no clinical signs of G VHR during the first 2 
weeks after transplantation, which was the time of 
maximum expression of G VHR in the control 
group, although residual activity remains in the 
Peyer's patches and the spieen of the recipients 30 
days after transplantation (Figure 9). This reactiv-
ity, however, decreases to zero 120 days postopera-
tively, thus proving irradiation to be effective for 
avoidance of G VHR over a long period of time. 
The most impressive results in the direction of 
circumventing G VHR were seen after the removal 
of the graft's mesenteric lymph nodes (Table III, 
Figure 9). The remaining measurable antihast ac-
tivity in the spieen was significantly lower than in 
Group 1 (p <0.002, 28.7 days postoperatively and p 
<0.05, 82.2 days postoperatively). These results 
show that the mesenteric lymph nodes of the graft 
are the tissue responsible for the development of 
G VHR. The T lymphocytes of the remaining 
Peyer's patches of the graft may develop antihost 
properties also, but these cells cannot elicit a GVHR 
that induces clinical symptoms. 
With regard to the clinical applicability of these 
experimental methods for the suppression of 
GVHR, administratio:rt of cyclosporine seems ap-
propriate for clinical use at the present time because 
it is already widely applied in transplantation. The 
methods involving irradiation of the graft and the 
removal of the mesenteric lymph nodes will have to 
be tested in experimental models of orthotopic non-
auxiliary small bowel replacement. Alteration of the 
small bowel mucosa by irradiation or interruption of 
the lymphatic vessels by extirpation of the lymph 
nodes might impair the resorptive function of the 
small bowel graft. These experimental regimens of 
donor, graft, and recipient treatment have proved 
their efficacy for circumventing GVHR, and thus 
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provide methods that are applicable in the clinical 
setting. 
Summary 
To describe G VHR in small bowel transplanta-
tion and its underlying mechanisms and to find 
methods for circumventing that response, accessory 
small bowel transplantation was carried out in the 
rat model. Animals not treated with cyclosporine, 
irradiation, or removal of the mesenteric lymph 
nodes of the graft died within 22 days postopera-
tively due to graft versus host disease. Mesenteric 
lymph nodes of the graft and recipient spieen and 
peripherallymph nodes showed strong immunolog-
ic stimulation histologically and high antihast T-
cell-mediated cytotoxic antihast reactivity. Seven-
ty-one percent of the animals that bad received 15 
mg of cyclosporine per kilogram body weight orally 
survived 150 days after transplantation. After do-
nor irradiation with 50 rads, 77 percent ofthe recipi-
ents survived 120 days. Mter microsurgical removal 
of the mesenteric lymph nodes of the graft, 89 per-
cent survived 120 days. 
We conclude that GVHR plays an important role 
insmall bowel transplantation and that the experi-
mental regimens of donor, graft, and recipient treat-
ment described herein have proved their efficacy for 
circumventing GVHR. 
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